FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994198804> ?p ?o ?g. }

• W1994198804 abstract "1. Studies have been made of the contractile responses to the alpha-adrenoceptor agonists phenylephrine (Phen), cirazoline (Cir) or BHT-920 (BHT) in dog isolated saphenous vein (DSV) rings, using the antagonists yohimbine (Yoh), idazoxan (Idaz), prazosin (Praz), WB-4101 (WB) and nitrendipine or zero Ca2+ medium. 2. Contractile concentration-response curves to Phen or BHT were displaced to the right of controls by Yoh (0.01-3 microM) with mean apparent antagonist dissociation constants (pKBs) of 7.9 and 8.6 respectively. Yoh did not show simple competitive antagonism against either agonist, since the Schild plot slopes were significantly less than unity. Neither the antagonist affinity of Yoh against Phen, nor the slope of the Schild plot was modified in the presence of catecholamine uptake inhibitors, nor in the presence of alpha,beta-methylene ATP, which desensitizes P2-purinoceptors, suggesting that Phen does not release ATP, or noradrenaline to cause contraction in DSV. In the presence of Praz (0.3 microM) the antagonist potency of Yoh (mean pKB 7.4) against Phen was slightly decreased. Yoh had low potency against responses induced by Cir (pKB 6.3). 3. WB (0.001-1.0 microM) was a very potent antagonist of Phen-induced contractions, however, the biphasic Schild plot against Phen could be separated into two affinity sites, a high pKB of 9.3 (equivalent to that obtained using Cir as the agonist; pKB 9.6) and a lower affinity (pKB 8.6). WB showed an even lower antagonist affinity (pKB 7.4) against BHT-induced contractions, suggesting that these effects might be mediated by alpha 2A-adrenoceptors. Praz also appeared to identify two sites using Phen-induced contractions, a high pKB of 8.4 was equivalent to that obtained with Cir (pKB 8.2) and a lower affinity site (pKB 7.7; pA2 7.6; slope 1.1) at which Praz showed competitive antagonism. Higher concentrations of Praz were required to antagonize contractions to BHT (pKB 5.9). 4. Idaz was a weak partial agonist in this tissue with threshold contractile effects at concentrations in excess of 3 microM. Idaz (0.1-1 microM) competitively antagonized the contractile effects of BHT, but showed low antagonist affinity against Phen at these concentrations. 5. Contractions to Phen were slightly antagonized by nitrendipine (1 microM), with a 36% decrease in Emax. Contractions to Phen and Cir were also markedly attenuated in zero calcium medium (with EGTA), but maximum responses of 4.2 +/- 0.1 and 3.6 +/- 0.1 g, could be obtained with these agonists respectively. Only part of the contractile effects to Phen or Cir are therefore due to calcium influx (but L-type channels are not totally implicated), while the contractile effects of BHT were abolished in zero Ca2 + medium. Yoh (0.1 microm) retained its antagonist effects on Phen-induced responses in zero Ca2 + medium. 6. The formation of inositol phosphates (InsPs) in the presence of lithium (10mM) was measured after incubation of intact DSV strips with myo-2-[3H]-inositol. Phen (1-1OO0 microM) and Cir (O.O1-1O microm) induced concentration-dependent increases in total labelled InsP1_3, but BHT showed minimal InsP stimulation. InsPs were recovered after Phen (100,M) stimulation (10min) as labelled InsP1 (71%), InsP2 (25%) and InsP3 (4%). Phen (100 microM)-stimulated InsP1-3 formation was significantly antagonized by Praz (10nM), but was not fully inhibited even after Praz 1 microM. Yoh and Praz (0.1 and 1.0 microM) were equipotent inhibitors of this response, while Idaz (0.3 microM) showed no effects. 7. The receptors in DSV which are stimulated by Phen to cause contraction show characteristics of the alpha lA-adrenoceptor (high pM antagonist affinity for WB-4101 and extracellular calcium sensitivity) and the alpha lB-adrenoceptor (contraction in calcium-free medium, increase in InsP and low nm antagonist affinity of WB). The paradoxical results obtained with Yoh (potent antagonist effects on Phen-stimulated PI and pKB 7.9 on contraction) and Praz (low affinity competitive antagonist of Phen-induced contraction, pKB 7.7 and failure to inhibit completely the PI response at 1 microM), cannot fully exclude an alpha 2B-subtype characterization of these responses. These pharmacological differences suggest that the adrenoceptor involved in the contractile and in particular the second messenger effects of Phen in DSV is not typically an alpha lB-adrenoceptor." @default.
• W1994198804 created "2016-06-24" @default.
• W1994198804 creator A5013700279 @default.
• W1994198804 creator A5017607970 @default.
• W1994198804 creator A5020582190 @default.
• W1994198804 creator A5046179528 @default.
• W1994198804 creator A5053574477 @default.
• W1994198804 creator A5085282983 @default.
• W1994198804 date "1991-01-01" @default.
• W1994198804 modified "2023-10-01" @default.
• W1994198804 title "α-Adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production" @default.
• W1994198804 cites W1775749144 @default.
• W1994198804 cites W1865252654 @default.
• W1994198804 cites W1910393924 @default.
• W1994198804 cites W1924734851 @default.
• W1994198804 cites W1935252133 @default.
• W1994198804 cites W1938018676 @default.
• W1994198804 cites W1953031441 @default.
• W1994198804 cites W1970448079 @default.
• W1994198804 cites W1971284770 @default.
• W1994198804 cites W1972189353 @default.
• W1994198804 cites W1983664314 @default.
• W1994198804 cites W1992160748 @default.
• W1994198804 cites W1997093700 @default.
• W1994198804 cites W1999465529 @default.
• W1994198804 cites W1999516979 @default.
• W1994198804 cites W1999956752 @default.
• W1994198804 cites W2000360015 @default.
• W1994198804 cites W2004400174 @default.
• W1994198804 cites W2006875910 @default.
• W1994198804 cites W2007003323 @default.
• W1994198804 cites W2009133356 @default.
• W1994198804 cites W2014740637 @default.
• W1994198804 cites W2020404323 @default.
• W1994198804 cites W2023665876 @default.
• W1994198804 cites W2025644899 @default.
• W1994198804 cites W2026186401 @default.
• W1994198804 cites W2030879302 @default.
• W1994198804 cites W2033653650 @default.
• W1994198804 cites W2036145275 @default.
• W1994198804 cites W2036725415 @default.
• W1994198804 cites W2043550188 @default.
• W1994198804 cites W2044349008 @default.
• W1994198804 cites W2049473805 @default.
• W1994198804 cites W2050729172 @default.
• W1994198804 cites W2051397699 @default.
• W1994198804 cites W2052526786 @default.
• W1994198804 cites W2057971042 @default.
• W1994198804 cites W2064461580 @default.
• W1994198804 cites W2066622502 @default.
• W1994198804 cites W2068877244 @default.
• W1994198804 cites W2076071445 @default.
• W1994198804 cites W2079876703 @default.
• W1994198804 cites W2091747024 @default.
• W1994198804 cites W2094119110 @default.
• W1994198804 cites W2111709073 @default.
• W1994198804 cites W2112139130 @default.
• W1994198804 cites W2157644893 @default.
• W1994198804 cites W2169383879 @default.
• W1994198804 cites W2226858109 @default.
• W1994198804 cites W2238525991 @default.
• W1994198804 cites W2245657173 @default.
• W1994198804 cites W2255861534 @default.
• W1994198804 cites W2261477455 @default.
• W1994198804 cites W2262861375 @default.
• W1994198804 cites W2263421427 @default.
• W1994198804 cites W2266011565 @default.
• W1994198804 cites W2267222614 @default.
• W1994198804 cites W2276635401 @default.
• W1994198804 cites W2281274074 @default.
• W1994198804 cites W2289078098 @default.
• W1994198804 cites W2339813706 @default.
• W1994198804 cites W2402968490 @default.
• W1994198804 cites W2416023448 @default.
• W1994198804 cites W2419241215 @default.
• W1994198804 cites W2467808079 @default.
• W1994198804 doi "https://doi.org/10.1111/j.1476-5381.1991.tb12146.x" @default.
• W1994198804 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1917904" @default.
• W1994198804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1675142" @default.
• W1994198804 hasPublicationYear "1991" @default.
• W1994198804 type Work @default.
• W1994198804 sameAs 1994198804 @default.
• W1994198804 citedByCount "24" @default.
• W1994198804 crossrefType "journal-article" @default.
• W1994198804 hasAuthorship W1994198804A5013700279 @default.
• W1994198804 hasAuthorship W1994198804A5017607970 @default.
• W1994198804 hasAuthorship W1994198804A5020582190 @default.
• W1994198804 hasAuthorship W1994198804A5046179528 @default.
• W1994198804 hasAuthorship W1994198804A5053574477 @default.
• W1994198804 hasAuthorship W1994198804A5085282983 @default.
• W1994198804 hasBestOaLocation W19941988042 @default.
• W1994198804 hasConcept C126322002 @default.
• W1994198804 hasConcept C134018914 @default.
• W1994198804 hasConcept C163415756 @default.
• W1994198804 hasConcept C170493617 @default.
• W1994198804 hasConcept C178790620 @default.
• W1994198804 hasConcept C185592680 @default.
• W1994198804 hasConcept C2776885963 @default.
• W1994198804 hasConcept C2777676773 @default.
• W1994198804 hasConcept C2777952589 @default.

• next